Stock Stories - Bamboo Works - China stock insights for global investors

Stories About 2480.HK

Luzhu Biotech earning report

Luzhu Biotech braces for make-or-break launch of shingles shot

2026-03-26

Luzhu's major products are currently in the research and development stage and it does not have any approved products for sale, and has suffered a loss of over 1.5 billion yuan in the past three years.

FAST NEWS: Luzhu Biotech repurchases shares

2024-07-16

Discover hidden China stock gems in our weekly newsletter

Follow us

Subscribe to Our Free eNewsletter

Check out our content with some of our syndication partners